Amplitude Ventures related stories
All articles and analysis
DrugBank lands C$9m in seed financing led by BrightsparkEdmonton-based DrugBank, a provider of structured drug data solutions, has collected C$9 million in seed financing.
Congruence Therapeutics picks up $50m in Series A fundingMontreal-based biotechnology startup Congruence Therapeutics has secured $50 million in Series A financing.
Gandeeva rakes in $40m Series A led by Lux, Leaps by BayerVancouver, British Columbia-based Gandeeva Therapeutics, a precision biotechnology company, has raised US$40 million in Series A funding.
Valence takes in $7m seed deal, Fifty Years, Air Street co-leadMontreal-based Valence Discovery, an artificial intelligence-enabled chemistry engine for treating intractable diseases, has raised $7 million in seed financing.
LQT Therapeutics nabs $19m in Amplitude-led Series A roundLaval, Quebec-based LQT Therapeutics, a pharmaceutical company focused on developing precision therapies for genetic heart diseases, has secured $19 in a Series A financing.
AI therapeutics platform Deep Genomics snags $180m Series CToronto-based Deep Genomics, an artificial intelligence therapeutics company, has raised $180 million in Series C financing.
Giiant Pharma adds to seed funding, AQC, CQDM investMontreal-based Giiant Pharma, developer of a precision delivery technology platform in gastroenterology, has raised an additional C$1.25 million for its seed financing.
Amplitude closes debut precision medicine fund at C$200m-plusCanadian venture capital firm Amplitude Venture Capital closed its debut precision medicine fund, securing its C$200 million target.
Amplitude, Genesys lead Giiant Pharma's $11m seed dealMontreal-based Giiant Pharma, developer of a precision delivery technology platform in gastroenterology, has secured $11 million (C$13.5 million) in a seed financing.
G2V Optics raises C$2.6m in funding led by Accelerate Fund IIEdmonton, Alberta-based smart lighting company G2V Optics has collected C$2.6 million in growth financing.